Search Results

Targeting GPRC5D for multiple myeloma therapy

• Authors : Zhou, Dian; Wang, Ying; Chen, Chong

• Source: Journal of Hematology & Oncology. September 28, 2024, Vol. 17 Issue 1

Record details

A Belantamab Mafodotin Revival in Multiple Myeloma Therapy.

• Authors : Trudel S; From the Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto.; Stewart AK

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy

• Source: The New England journal of medicine [N Engl J Med] 2024 Aug 01; Vol. 391 (5), pp. 461-462.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

[Construction of CD138-targeted chimeric antigen receptor- modified T cells and their effect in multiple myeloma therapy].

• Authors : Guo CC; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China Tianjin Institutes of Health Science, Tianjin 301600, China.; Lu Y

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/immunology ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/immunology

• Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2024 May 14; Vol. 45 (5), pp. 436-444.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium: Print ISSN: 0253-2727

Record details

Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.

• Authors : Liu Z; Department of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300052, PR China; Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, 154 Anshan Street, Heping District, Tianjin 300052, PR China. Electronic address: .

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/metabolism ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology

• Source: Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2024 Apr; Vol. 76, pp. 1-11. Date of Electronic Publication: 2024 Feb 15.Publisher: Elsevier Science Country of Publication: England NLM ID: 9612306 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy.

• Authors : Yang M; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou 310027, China.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; MicroRNAs*

• Source: Biomolecules [Biomolecules] 2024 Jan 09; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy.

• Authors : Morales-Martínez M; Molecular Signal Pathway in Cancer Laboratory, UIMEO, Oncology Hospital, Siglo XXI National Medical Center, Mexican Institute of Social Security (IMSS), Mexico City 06720, Mexico.; Vega MI

• Source: Cancers [Cancers (Basel)] 2024 Jan 06; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

Record details

Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting

• Authors : Zhao, Juanjuan; Ren, Quan; Liu, Xinyuan

• Source: Journal of Hematology & Oncology. August 3, 2023, Vol. 16 Issue 1

Record details

Cellular immunity in the era of modern multiple myeloma therapy.

• Authors : Liu Z; Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, China.; Zhao X

Subjects: Multiple Myeloma*; Humans ; Immunotherapy

• Source: International journal of cancer [Int J Cancer] 2023 Oct 15; Vol. 153 (8), pp. 1436-1447. Date of Electronic Publication: 2023 Jun 12.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

siRNA Lipid-Polymer Nanoparticles Targeting E-Selectin and Cyclophilin A in Bone Marrow for Combination Multiple Myeloma Therapy.

• Authors : Figueroa-Espada CG; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, 240 Skirkanich Hall, 210 South 33rd Street, Philadelphia, PA 19104 USA.; Guimarães PPG

• Source: Cellular and molecular bioengineering [Cell Mol Bioeng] 2023 Sep 14; Vol. 16 (4), pp. 383-392. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).Publisher: Springer Country of Publication: United States NLM ID: 101468590 Publication Model: eCollection Cited Medium: Print ISSN: 1865-5025

Record details

Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF.

• Authors : He, Chao; Zhang, Manqi; Liu, Lingling

Subjects: MULTIPLE myeloma; B cells; ANTIGENS

• Source: Acta Biomaterialia; Apr2022, Vol. 143, p406-417, 12p

Record details